Drug intelligence / Profile preview

2h-AFL-PDT

Development stage
Unknown
Lead developer
Dong-A University
Modality
Small Molecules, Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

2h-AFL-PDT is a combination therapeutic protocol developed for the treatment of actinic keratosis, particularly on the face and scalp. The procedure begins with pretreatment using an Erbium:yttrium-aluminium-garnet (Er:YAG) ablative fractional laser (AFL), which creates microscopic treatment zones to enhance the skin's permeability. This is followed by the topical application of methyl aminolevulinate (MAL) cream, which is incubated for a shortened duration of 2 hours. During this time, MAL is preferentially taken up by dysplastic cells and converted into the endogenous photosensitizer protoporphyrin IX (PpIX). The area is then irradiated with a red light-emitting diode (LED) lamp, which excites the PpIX, leading to the production of reactive oxygen species and subsequent selective destruction of the actinic keratosis lesions. This protocol aims to maintain high efficacy while reducing the traditional 3-hour incubation time, thereby improving patient convenience and potentially reducing treatment-related pain.

Other names
2-hour ablative fractional laser-assisted photodynamic therapyAFL-assisted MAL-PDT with 2-hour incubation2h-AFL-PDT-Dong-A University-actinic keratosis

Beyond the preview

Go deeper on 2h-AFL-PDT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2h-AFL-PDT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call